Streetwise Reports' Article Archives — October 2019 back to current month (143)
This exploration tool also assists the property's explorer with outcrop detection.
The Canadian company will provide its remote patient monitoring and chronic care management software solutions to these two U.S. enterprises.
The well is expected to be put in production within about seven days.
Growth has been rapid in all of its sales verticals.
The Canadian company achieves this through underground channel sampling.
Shares of gold royalty firm Sandstorm Gold traded more than 9% higher today after reporting record revenue for Q3/19.
Calibre Buys Two Gold Mines from B2 Gold (10/31/2019)
Bob Moriarty of 321gold presents the investment thesis for this mining firm.
Shares of Crocs Inc. traded 15% higher at times today reaching a 52-week intraday high price after the firm reported Q3/19 earnings and raised its FY/19 guidance.
The highlights of this Canadian company's cornerstone asset are outlined in an Echelon Wealth Partners report.
The reasons behind this opinion are presented in a CIBC report.
Bob Moriarty of 321 Gold discusses how recent Fed actions are affecting the markets, as well as what a gold explorer's recent NI 43-101 reports means.
Operational Improvements Boost Yamana (10/30/2019)
Money manager Adrian Day updates developments at several resource companies, with one strong buy.
In conversation with Brien Lundin of the Gold Newsletter and the organizer of the New Orleans Investment Conference, Maurice Jackson of Proven and Probable explores the geopolitical, financial, practical and social issues surrounding investment in the precious metals.
Shares of Navidea Biopharmaceuticals traded 60% higher today on extremely high relative volume after the firm released data from its Phase 2b Rheumatoid Arthritis Tc 99m Tilmanocept Planar Imaging study.
The energy storage firm sees another solid month of new orders.
Recent developments on several of this North American explorer's prospects are discussed in an interview with Maurice Jackson of Proven and Probable.
The recent results and their implications are provided in an H.C. Wainwright & Co. report.
Observations from a recent site visit there are provided in a BMO Capital Markets report.
Energy Company Divests Stake in Offshore Gasfield (10/28/2019)
How the transaction benefits the London-based oil and gas firm is outlined in a Pareto Securities report.
The test results and next steps are provided in a Mackie Research Capital Corp. report.
A description of and comments about the play, an acquisition, are provided in a Raymond James report.
The package encompasses wearable devices, two-way video communication and geofencing.
The engineering department expects to complete the work by the end of this year.
This will allow the developer to evaluate its product in a bustling environment in which cruise ship passengers and cargo routinely come and go.
The new additions to its existing platform tackle these problems: shootings of officers and entry of active assailants into buildings.
Shares of IVERIC bio opened nearly 100% higher today after reporting that it successfully met its primary endpoint in its Phase 2b age-related macular degeneration study for Zimura.
The arrangement highlights the Vancouver company's readiness to capture further market share in the province.
To do so, the company will leverage the various components of its AR platform.
This approach mirrors what owners of comparable projects have done in the past.
The next milestone for the Canadian company is submission of its application for permits.
Gold Company Plans Drilling Launch for November (10/26/2019)
The purpose is to follow up on identified high-grade gold anomalies.
Both appointees have years of experience in the field.
Sector expert Michael Ballanger ruminates on the bubble-popping influence of government and the banking sector on cryptocurrencies, and offers a brief rundown on his most current holdings.
Shares of respiratory medical device maker and software applications company ResMed Inc. traded 15% higher at times today after the firm posted positive Q1/20 earnings results.
These rooftop projects are expected to generate $2.1-plus million over their lifetime for the New York-based company.
The company completes the supply chain information transfer to manufacturing giant Jaybil.
The platform uses blockchain technology to make the data immutable.
Shares of Varian Medical Systems traded 10% higher at times today after the company reported quarterly and annual earnings. The company increased revenue 10% year-over-year and provided FY/20 guidance.
Online customers will be able to see what selected eyeglasses look like on their face in real time.
With all three zones open downplunge, the Canadian company intends to continue drilling.
Oil Producer Closes Two Sales of Assets (10/23/2019)
Together, the transactions yielded CA$912 million for the energy firm.
The results and commercial potential of the therapeutic are discussed in an H.C. Wainwright & Co. report.
The primary aim of the firm's technology platform is to support remote patient monitoring.
These therapeutic candidates add to those already in the firm's pipeline.
This morning shares of Boston Scientific traded 6% higher after the firm reported a 13.1% increase in revenue for Q3/19. The firm also raised its revenue guidance for both Q4/19 and FY/19.
John-Mark Staude, president and CEO of Riverside Resources, speaks with Maurice Jackson of Proven and Probable about his company's strategic funding agreement with BHP to explore the Laramide copper belt of Sonora.
Frank Holmes: Gold Is Going to $10,000 (10/22/2019)
Frank Holmes, CEO of U.S. Global Investors, discusses why he believes gold will go to $10,000, weighs in on the cryptocurrency versus gold debate, and explains why his gold and precious metals ETF is outperforming its peers, naming some of its top performing companies.
Shares of Biogen Inc. opened nearly 39% higher today after the firm announced plans to submit a Biologics License Application to the FDA in early 2020 for its Alzheimer's drug aducanumab based on new analysis of larger datasets from two phase 3 studies. The company also announced Q3/19 earnings today.
Thibaut Lepouttre of Caesars Report profiles this company exploring its large land package in Finland's greenstone belt.
These further drill results are positive and consistent with previous ones.
Trenching yielded some of the highest-grade results to date.
The details of this study and a second one are outlined in a ROTH Capital Partners report.
The factors at play in the company's recent quarterly output are provided in a Pareto Securities report.
Halliburton Shares Trade Higher on Q3 Earnings (10/21/2019)
Shares of Halliburton Co. at times traded greater than 8% higher after the firm reported improved Q3/19 earnings results versus Q2/19.
Maurice Jackson of Proven and Probable speaks with the CEO of a company upping its game in silver districts in the Yukon and Colorado.
Sprott made the purchase through a private agreement.
Newly released financials included all of the costs of the recent acquisition but only three days of related sales.
The ball club and the product developer will begin deploying it shortly.
The company is now planning a drill campaign there.
This was the conclusion drawn from the recent sequential copper analysis.
The Canadian company will investigate it with field work and possibly drilling.
It also aims for revenue growth next year of at least 50%.
Mining Company Updates PEA for Ontario Project (10/20/2019)
This is a step forward as the firm continues to advance and derisk the project.
Q4 Guesstimates: Precious Metals, Miners and Stocks (10/20/2019)
Sector expert Michael Ballanger reflects on modern monetary policy and discusses his most recent investment decisions.
The production numbers are reviewed in a BMO Capital Markets report.
John Newell of Fieldhouse Capital Management explores the investment opportunities presented by this project generator in a district rich with historical mine strikes.
Dermira shares traded higher today after the firm released positive data from its phase 2b study of lebrikizumab in patients with atopic dermatitis at the Las Vegas Fall Clinical Dermatology Conference.
Seplat Petroleum to Acquire Eland Oil & Gas (10/17/2019)
A glance at the deal is provided in a Pareto Securities report.
Shares of Protalix Biotherapeutics skyrocketed today on much higher than average volume as the firm announced positive 12-month interim data from its BRIDGE Phase 3 open label switch-over study of pegunigalsidase alfa (PRX-102) for the treatment of Fabry disease.
This marks the product developer's entry into a new segment of the public venues market.
The company expects action by President Trump following the nuclear fuel working group's recommendations.
The transaction details are relayed in a CIBC report.
Drilling is about to start at one of the company's projects and continues at the other two.
Accordingly, the company continues an expanded, aggressive stepout drill program there.
Healthcare Tech Firm Signs Five New Clients in Texas (10/16/2019)
The company just landed another five clients in Texas and now plans to build out sales teams in five additional states.
Pan Orient Energy: The New Orient Express (10/16/2019)
Veteran investor and newsletter writer Chen Lin explains the upside he sees with this energy company.
Shares of Achillion Pharmaceuticals are trading much higher today after the firm reported that it has agreed to be acquired by Alexion Pharmaceuticals for $930 million, or $6.30 per share in cash, along with the potential for an additional $2 per share if certain other specific clinical trial and regulatory milestones are met.
It did this through capital improvements at each of its various facilities.
The purchase expands the holdings of its principal project there.
Good news is piling up for this healthcare stock engaged in the treatment of hepatitis B as it trades at 5X its average volume with a 30% stock price gain over previous close.
Skyharbour Drilling Deeper in Athabasca Basin (10/16/2019)
Jordan Trimble, CEO of Skyharbour Resources, sits down with Maurice Jackson of Proven and Probable to discuss his company's exploration plans in Canada's uranium-rich Athabasca Basin.
Platinum Group Metal Cowboys in Montana (10/15/2019)
A small-cap company in Montana is exploring to find out if its property contains "Platreef-style" PGE mineralization.
The goal is to reduce the time healthcare workers spend on mundane tasks and thereby improve patient care.
Shares of Relmada Therapeutics have traded wildly today after it announced Phase 2 results for its anti-depressant drug dextromethadone. The firm's shares have traded 100–200% higher today and the stock was halted several times trading due to extreme price volatility.
The company will use these new data in designing the mine and optimizing the prefeasibility study.
Q3/19 production totals from the company's various assets are discussed in a CIBC report.
Technical analyst Clive Maund outlines the reasons this stock might break higher.
Prominent Gold Stock at 'Buy Spot' (10/14/2019)
Technical analyst Clive Maund's charts explain why he sees this stock as a buy.
Maurice Jackson of Proven and Probable discusses the latest developments in the Goodpaster District with this company's chief executive and senior geologist.
Shares of Cerecor Inc. are trading higher today after reporting that it will sell its pediatric portfolio to Aytu BioScience for $32 million in a combination cash and stock deal.
Also, a geochemical survey identifies four new exploration targets.
Explorer a 'Highly Attractive Speculative Play' (10/12/2019)
This miner has taken a hit, but technical analyst Clive Maund explains why the stock may be a good buy at current levels.
Technical analyst Clive Maund believes this stock could gain traction soon.
These results are from one of the company's high-priority regional prospects.
Recent assays demonstrate high prospectivity between two existing zones.
Energy Stock Is 'Looking to Break Out of Large Base' (10/11/2019)
Technical analyst Clive Maund explains why he believes this company with projects in Thailand and Indonesia is about ready to start another upleg.
Junior Gold Stock 'On the Up' (10/11/2019)
Technical analyst Clive Maund charts a junior explorer and explains why he sees it as a speculative buy.
Shares of Reata Pharmaceuticals are trading 12% higher today after the firm announced it had reacquired all licensing rights in the U.S. for bardoxolone methyl and worldwide rights for omaveloxolone and other next-generation Nrf2 activators from AbbVie.
Sector expert Michael Ballanger's take on this week's news from the financial markets informs his most recent investment decisions.
Shares of Ra Pharmaceuticals doubled today after the firm announced that it will be acquired by Belgian firm UCB for $48 per share in an all cash deal.
The changes made and the reasons for them are detailed in a Raymond James report.
Through continued drilling, the Canadian company is pursuing further extensions.
The pros and cons of the deal are discussed in an iA Securities report.
The details regarding those metals sales are provided in a BMO Capital Markets report.
The partnership could put both companies at the forefront of the emerging 3D-AR market.
The developer received an initial order from Taiwan for the product.
Thailand Exploration Well Hits Net Oil Pay (10/09/2019)
The well will be production tested after the required permit is obtained.
Soliton Inc. shares traded 10% higher today after advising that later this month it will present the data from clinical trials for its Rapid Acoustic Pulse device used in the treatment of keloid and hypertrophic scars at the American Society for Dermatologic Surgery Annual Meeting.
Chris Taylor, CEO of Great Bear Resources, speaks to Maurice Jackson of Proven and Probable about what the drills are turning up at the Dixie Gold Project in Ontario's Red Lake District.
Brazil Mine 'Demonstrates Growth is Real' (10/08/2019)
Conclusions from a recent site visit are delivered in a CIBC report.
Data from this study should be released by the end of this year.
The key reasons this story is compelling are given in an H.C. Wainwright & Co. report.
Progress has been made in all areas, from testing the product to evaluating distributors.
Shares of Nordic American Tankers are trading 16.5% higher today setting a 52-week intraday high stock price as the company reported great demand for its Suezmax oil tankers.
The company reported its FY19 revenue and profit and FY20 financial goal.
Management presented its recent, major corporate developments and product changes.
This is another addition to the Vancouver-based company's growing asset portfolio.
These increases indicate an "attractive, near-term development opportunity," the company states.
This will help its customers access the products and tools they need more sustainably.
The Critical Investor digs into what the proposed joint venture means for this junior project generator.
Akcea Therapeutics' shares are trading 30% higher today on news that it has entered into a worldwide exclusive licensing agreement with Pfizer for AKCEA-ANGPTL3-LRx used in the treatment of patients with cardiovascular and metabolic diseases.
Analyst: Gold Explorer Warrants Top Pick Status (10/07/2019)
The rationale for this view of the company is provided in an Echelon Wealth Partners report.
Free Market Capitalism: Laughably Predictable (10/05/2019)
Sector expert Michael Ballanger offers his observations on recent market fluctuations.
The Canadian company will look to its new board head for strategic leadership.
Now, the company is completing a helicopter-supported field program there.
Healthcare Tech Firm Expands Patient Base in Texas (10/04/2019)
The company landed five new U.S. facilities as customers.
Shares of RingCentral and Avaya Holdings are soaring today after the announcement that RingCentral will become Avaya's exclusive Unified Communications as a Service (UCaaS) solutions provider.
The deal and the assets are described in a ROTH Capital Partners report.
The drill results are relayed and interpreted in a Haywood report.
In a research report, Raymond James revisits and revises its Q3/19 projections on this company.
This morning PDS Biotechnology Corp. shares are trading 38% higher after reporting that it will enter into a clinical collaboration with Merck pairing the firm's PDS0101 with KEYTRUDA for patients with recurrent or metastatic head and neck cancer and high-risk HPV16 infection.
After years of work, this milestone is a significant one for the process and the company's development.
The goals are to test for a greater depth of the current resource and for high-grade feeder structures.
One area of mineralization encountered could represent a third discovery zone.
This is the eighth public facility to partner with the product's developer in this way.
Non-invasive medical device maker Zynex Inc's. shares are trading 12% higher on an overall down market day after the company reported that Q3/19 orders are up 95% over the same period in 2018.
Teekay Offshore Partners shares are trading more than 30% higher today on news that Brookfield Business Partners will be purchasing all un-owned common units of the firm for $1.55 per share.
The multiplatform technology to be provided will allow for mobile, virtual product demonstrations.
Agreement Reached on Royalty on Quebec Project (10/01/2019)
The asset's operator and its royalty holder have reached agreement and clarified the terms of the royalty.
A new collaboration will ensure compliance with wireless, electromagnetic compatibility and safety standards.
This is because the trio shares similar and correlatable geology and/or mineralization styles.
Maple Gold for $3.02 an Ounce US (10/01/2019)
Bob Moriarty of 321 Gold explains why he has been buying shares of this gold explorer with a project in Quebec.
Deflation or Inflation: Gold Doesn't Care (10/01/2019)
Rudi Fronk and Jim Anthony, cofounders of Seabridge Gold, discuss recession, central bank panic and an outrageous gold price.
|"DV commenced drilling at its namesake silver project."|
|"PHNM presents the opportunity to get in early on a promising exploration target in the Carlin gold trend, while benefitting from the potential for a rising vanadium market."|
|"I see the risk/reward for SIG as highly favorable."|
|"I expect more high grade joy out of KLD's Regnault."|
|"We are initiating coverage on EMO with a Speculative Buy rating."|